Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes

    Didem Kazan, Defne Özkoca, Nazlı Dizen Namdar
    TLDR COVID-19-related hair loss may have unique features compared to hair loss from other causes.
    The study "Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes" investigates the characteristics of telogen effluvium (TE) in patients with SARS-CoV-2 infection compared to TE from other causes. The research highlights that TE is a prevalent form of non-cicatricial alopecia among COVID-19 patients. The findings suggest that while TE can be triggered by various factors, the incidence and presentation in COVID-19 patients may have distinct features, potentially due to the physiological and psychological stress associated with the infection. Understanding these differences is crucial for developing targeted treatment strategies for TE in the context of COVID-19.
    Discuss this study in the Community →

    Cited in this study

    21 / 21 results